This trial demonstrated that Ozempic®, a GLP-1 receptor agonist, significantly reduces the risk of progression in chronic kidney disease and cardiovascular mortality in patients with type 2 diabetes.
Kidney doctors are called nephrologists. They treat conditions that affect the kidneys, like chronic kidney disease and kidney stones. They also may help people manage chronic conditions like diabetes ...